Browsing Tag
Roluperidone
1 post
Minerva Neurosciences gains up to $200m to advance Roluperidone toward FDA approval and U.S. market launch
Minerva Neurosciences secures up to $200 million to fund a new Phase 3 trial of Roluperidone and prepare for a potential U.S. launch. Find out what’s next.